Neuroprotective effects of PRG on Aβ25-35-induced cytotoxicity through activation of the ERK1/2 signaling pathway

• Published in: Journal of ethnopharmacology Vol. 313; p. 116550
• Main Authors: Bian, Zhiying, Cao, Chenzhen, Ding, Jie, Ding, Liang, Yu, Shuai, Zhang, Chuanxiang, Liu, Qian, Zhu, Lihao, Li, Jing, Zhang, Yongqing, Liu, Yuhong
• Format: Journal Article
• Language: English
• Published: Elsevier B.V 15.09.2023
• Subjects: Alzheimer's disease; Aβ25–35; ERK1/2; PC12 cells; Phylloporia ribis; Polysaccharide; PC12 cells; ERK1/2; Alzheimer's disease; Polysaccharide; Phylloporia ribis; Aβ25–35
• ISSN: 0378-8741; 1872-7573
• DOI: 10.1016/j.jep.2023.116550

Phylloporia ribis (Schumach:Fr.)Ryvarden is a genus of needle Phellinus medicinal fungi, parasitic on the living rhizomes of hawthorn and pear trees. As a traditional Chinese medicine, Phylloporia ribis was used in folklore for long-term illness, weakness and memory loss in old age. Previous studies have shown that polysaccharides from Phylloporia ribis (PRG) significantly promoted synaptic growth in PC12 cells in a dose-dependent manner, exhibiting “NGF”-like neurotrophic activity. Aβ25-35 damage to PC12 cells produced neurotoxicity and decreased cell survival, and PRG reduced the apoptosis rate, suggesting that PRG has neuroprotective effects. The studies confirmed that PRG had the potential to be a neuroprotective agent, but its neuroprotective mechanism remained unclear. We aimed to elucidate the neuroprotective effects of PRG in an Aβ25-35-induced Alzheimer's disease (AD) model. Highly-differentiated PC12 cells were treated with Aβ25-35 (AD model) and PRG, and were assessed for cellular apoptosis, inflammatory factors, oxidative stress, and kinase phosphorylation. The results showed that the PRG groups effectively inhibited the neurotoxicity, mainly manifested by inhibiting mitochondrial oxidative stress, attenuating neuroinflammatory responses, and improving mitochondrial energy metabolism, eventually resulting in higher cell survival. The expression of p-ERK, p-CREB and BDNF proteins was increased in the PRG groups compared to the model group, which confirmed that PRG reversed the inhibition of the ERK pathway. We provide evidence for neuroprotection conferred by PRG and its mechanism by inhibiting ERK1/2 hyper-phosphorylation, prevention of mitochondrial stress, and subsequent prevention of apoptosis. The study highlights PRG as a promising candidate with neuroprotective effects, the potential of which can be harnessed for identifying novel therapeutic targets. [Display omitted]